The inhibitory effects of thapsigargin, cyclopiazonic acid, and 2,5-di(tert-butyl)hydroquinone, and 1,3-dibromo-2,4,6-tri(methylisothiouronium)benzene on the Ca 2ϩ ATPase were characterized by comparative measurements of sequential reactions of the catalytic and transport cycle, including biochemical measurements and detection of charge movements within a single cycle. In addition, patterns of ATPase proteolytic digestion with proteinase K were derived to follow conformational changes through the cycle or after inhibitor binding. We find that thapsigargin, cyclopiazonic acid, and 2,5-di(tert-butyl)hydroquinone inhibit Ca 2ϩ binding and catalytic activation as demonstrated with isotopic tracers and lack of charge movement upon addition of Ca 2ϩ in the absence of ATP. It has been shown previously that binding of these inhibitors requires the E2 conformational state of the ATPase, obtained in the absence of Ca 2ϩ . We demonstrate here that E2 state conformational features are in fact induced by these inhibitors on the ATPase even in the presence of Ca 2ϩ . The resulting dead-end complex interferes with progress of the catalytic and transport cycle. Inhibition by 1,3-dibromo-2,4,6-tri(methylisothiouronium)benzene, on the other hand, is related to interference with a conformational transition of the phosphorylated intermediate (E1ϳP ⅐ 2Ca 2ϩ to E2-P ⅐ 2Ca 2ϩ transition), as demonstrated by increased phosphoenzyme levels and absence of bound Ca 2ϩ translocation upon addition of ATP. This transition includes large movements of ATPase headpiece domains and transmembrane segments, produced through utilization of ATP-free energy as the "conformational work" of the pump. We conclude that the mechanism of high-affinity Ca 2ϩ ATPase inhibitors is based on global effects on protein conformation that interfere with ATPase cycling.